Why Retatrutide May Outperform GLP-1 Drugs
From The Metabolic Classroom with Dr. Ben Bikman by Insulin IQ
May 25, 2026 · 27 min · Episode 151
About this episode
Dr. Ben Bikman discusses retatrutide, a next-generation metabolic drug that activates multiple receptors to aid in appetite suppression and energy expenditure.
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Retatrutide activates GLP-1, GIP, and glucagon receptors, combining appetite suppression with increased energy expenditure and powerful liver fat reduction. Dr. Bikman argues that its best use is not as a permanent shortcut, but as a tool to help people regain control over food habits and eventually reduce reliance on medication. Summary: Dr. Ben Bikman explains retatrutide, a next-generation metabolic drug that activates three receptors at once: GLP-1, GIP, and glucagon. While semaglutide targets GLP-1 and tirzepatide targets GLP-1 plus GIP, retatrutide adds a third arm through glucagon receptor activation. This makes it distinct because GLP-1 and GIP mainly reduce food intake, while glucagon adds an energy-output effect by increasing fat oxidation, liver fat clearance, and energy expenditure. Dr. Bikman focuses especially on glucagon because it is the novel feature of retatrutide. In the liver, glucagon stimulates fat burning, suppresses new fat production, promotes hepatic fat clearance, and increases…
People in this episode
Host: Dr. Ben Bikman
Topics covered
- metabolic drugs
- appetite suppression
- energy expenditure
- liver fat reduction
- food habits
- medication reliance
Keywords
- retatrutide
- GLP-1
- GIP
- glucagon
- energy expenditure
- liver fat
- body weight
- fat oxidation
Mentioned in this episode
Organizations: Insulin IQ
Products: Retatrutide, GLP-1, semaglutide, tirzepatide
More episodes of The Metabolic Classroom with Dr. Ben Bikman
- Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of · June 8, 2026 · 21 min
- Why Your Ketone Readings Don’t Match · June 1, 2026 · 29 min
- Why Tirzepatide Works Better Than GLP-1 Alone · May 18, 2026 · 33 min
- The Hidden Signals That Make Fat Cells Grow · May 11, 2026 · 30 min
- Why Neuropathy Isn’t Just About Blood Sugar · May 4, 2026 · 23 min
- How Your Brain Talks to Your Pancreas (The Vagus Nerve Explained) · April 27, 2026 · 28 min
Explore listener stats, chart rankings, contacts and more on the The Metabolic Classroom with Dr. Ben Bikman podcast page.